MP-424 (Telaprevir)

DRUG2 trials

Sponsors

Tanabe Pharma Corporation

Conditions

Chronic Hepatitis CHepatitis C

Phase 1

Safety and PK Study of MP-424 to Treat Chronic Hepatitis C

CompletedNCT00591214

Tanabe Pharma CorporationChronic Hepatitis C

Start: 2007-12-31End: 2008-10-31Updated: 2026-01-06

Phase 2

Safety and Efficacy of MP-424 to Treat Chronic Hepatitis C

CompletedNCT00621296

Tanabe Pharma CorporationHepatitis C

Start: 2008-01-31End: 2009-02-28Updated: 2026-01-06